Subscription AgreementSubscription Agreement • August 8th, 2017 • Biotechnology Value Fund L P • Investment advice • New York
Pursuant to the terms and conditions of this Subscription Agreement (this “Agreement”), the undersigned investors (each, an “Investor”) hereby confirms and agrees with BioLineRx Ltd., a corporation organized under the laws of the State of Israel (the “Company”), as follows:
VOTING AND STANDSTILL AGREEMENTVoting and Standstill Agreement • August 8th, 2017 • Biotechnology Value Fund L P • Investment advice • New York
This VOTING AND STANDSTILL AGREEMENT (this “Agreement”), dated as of July 26, 2017, is entered into between BioLineRx Ltd. (“BioLineRx” or the “Company”) and Biotechnology Value Fund, together with any affiliates, control persons, nominees or others under common control (“BVF”).
JOINT FILING AGREEMENTJoint Filing Agreement • August 8th, 2017 • Biotechnology Value Fund L P • Investment advice
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D dated August 7, 2017 (including amendments thereto) with respect to the shares of Ordinary Shares, par value NIS 0.10 per share, of BioLineRx Ltd. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
